Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug-Eluting Balloons and Drug-Eluting Stents in Diabetic Patients Undergoing Percutaneous Coronary Intervention Due to Restenosis-DM-Dragon Registry.
Niezgoda P, Kasprzak M, Kubica J, Kuźma Ł, Januszek R, Iwańczyk S, Tomasiewicz B, Bil J, Kowalewski M, Jaguszewski M, Wybraniec M, Reczuch K, Dobrzycki S, Bartuś S, Lesiak M, Gąsior M, Wolny R, Witkowski A, Gil R, Cortese B, D'Ascenzo F, Wojakowski W, Wańha W. Niezgoda P, et al. Among authors: kasprzak m. J Clin Med. 2024 Jul 30;13(15):4464. doi: 10.3390/jcm13154464. J Clin Med. 2024. PMID: 39124731 Free PMC article.
ACS network-based implementation of therapeutic hypothermia for the treatment of comatose out-of-hospital cardiac arrest survivors improves clinical outcomes: the first European experience.
Kozinski M, Pstragowski K, Kubica JM, Fabiszak T, Kasprzak M, Kuffel B, Paciorek P, Navarese EP, Grzesk G, Kubica J. Kozinski M, et al. Among authors: kasprzak m. Scand J Trauma Resusc Emerg Med. 2013 Mar 25;21:22. doi: 10.1186/1757-7241-21-22. Scand J Trauma Resusc Emerg Med. 2013. PMID: 23531402 Free PMC article.
Prasugrel overcomes high on-clopidogrel platelet reactivity in the acute phase of acute coronary syndrome and maintains its antiplatelet potency at 30-day follow-up.
Koziński M, Obońska K, Stankowska K, Navarese EP, Fabiszak T, Stolarek W, Kasprzak M, Siller-Matula JM, Rość D, Kubica J, De Servi S. Koziński M, et al. Among authors: kasprzak m. Cardiol J. 2014;21(5):547-56. doi: 10.5603/CJ.a2014.0026. Epub 2014 Mar 27. Cardiol J. 2014. PMID: 24671900
Prediction of high risk of non-adherence to antiplatelet treatment.
Kubica A, Obońska K, Kasprzak M, Sztuba B, Navarese EP, Koziński M, Świątkiewicz I, Kieszkowska M, Ostrowska M, Grześk G, Kubica J. Kubica A, et al. Among authors: kasprzak m. Kardiol Pol. 2016;74(1):61-7. doi: 10.5603/KP.a2015.0117. Epub 2015 Jun 23. Kardiol Pol. 2016. PMID: 26101025 Free article.
The impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial.
Obońska K, Kasprzak M, Sikora J, Obońska E, Racki K, Goździkiewicz N, Krintus M, Kubica J. Obońska K, et al. Among authors: kasprzak m. Trials. 2017 Jul 11;18(1):316. doi: 10.1186/s13063-017-2047-8. Trials. 2017. PMID: 28697767 Free PMC article. Clinical Trial.
177 results